These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1782280)

  • 1. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
    Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
    Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of N-terminal procollagen peptide of collagen type III in schistosomal liver fibrosis.
    el-Mohandes M; Hassanein H; el-Badrawy N; Voss B; Gerlach U
    Exp Mol Pathol; 1987 Jun; 46(3):383-90. PubMed ID: 3109933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease.
    Shahin M; Schuppan D; Waldherr R; Risteli J; Risteli L; Savolainen ER; Oesterling C; Abdel Rahman HM; el Sahly AM; Abdel Razek SM
    Hepatology; 1992 Apr; 15(4):637-44. PubMed ID: 1551641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.
    Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I
    Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum type III procollagen peptides in patients with hepatointestinal and compensated hepatoesplenic schistosomiasis forms.
    Mincis M; Braga LL; Russo EM; Novo NF; Juliano Y
    Arq Gastroenterol; 1990; 27(1):24-9. PubMed ID: 1978659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
    Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
    Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis.
    Hayasaka A; Koch J; Schuppan D; Maddrey WC; Hahn EG
    J Hepatol; 1991 Nov; 13(3):328-38. PubMed ID: 1725528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
    Kürkçüoğlu N; Oz G
    J Am Acad Dermatol; 1992 Jul; 27(1):139. PubMed ID: 1619068
    [No Abstract]   [Full Text] [Related]  

  • 11. Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity.
    Diodati G; Bonetti P; Plebani M; Giacomini A; Rugge M; Realdi G; Burlina A
    Ric Clin Lab; 1990; 20(4):253-9. PubMed ID: 2075377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H; Søgaard H; Heickendorff L
    Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
    Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
    Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis.
    Gabrielli GB; Capra F; Casaril M; Squarzoni S; Tognella P; Dagradi R; De Maria E; Colombari R; Corrocher R; De Sandre G
    Clin Chim Acta; 1997 Sep; 265(1):21-31. PubMed ID: 9352126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.
    Bentsen KD; Hørslev-Petersen K; Junker P; Juhl E; Lorenzen I
    Liver; 1987 Apr; 7(2):96-105. PubMed ID: 3613881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
    Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
    Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis.
    Rojkind M
    Hepatology; 1984; 4(5):977-8. PubMed ID: 6479861
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevation of laminin and beta-subunit of prolyl 4-hydroxylase in the sera of human subjects with Schistosomiasis mansoni.
    Tanabe M; Sekiguchi T; Kaneko N; Kobayashi S; Takeuchi T; Coutinho A; Tateno S; Maruyama K; Okazaki I
    Jpn J Exp Med; 1989 Jun; 59(3):109-19. PubMed ID: 2554032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction.
    Zwingenberger K; Richter J; Vergetti JG; Feldmeier H
    Trans R Soc Trop Med Hyg; 1990; 84(2):252-6. PubMed ID: 2117787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
    Gressner AM; Tittor W; Negwer A
    Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.